Diagnostic utility of BRCA1-associated protein 1 (BAP1), Programmed Cell Death4 (PCD4) and Epithelial membrane antigen (EMA) expression in differentiation of malignant mesotheliom

Histopathological and Immunohistochemical Study of D2-40 Expression in Malignant Pleural Mesothelioma and Metastatic Adenocarcinoma

Immunohistochemical Sox2 expression in lung squamous cell carcinoma and adenocarcinoma stage III-IV

CLINICOPATHOLOGICAL SIGNIFICANCE OF PROGRAMED DEATH -LIGAND -1(PD-L1) AND PROLIFERATION CELL NUCLEAR ANTIGE(PCNA)EXPRESSION IN PROSTATIC CARCINOMA; AN IMMUNOHISTOCHEMICAL STUDY"

Comparative study of BAP1 and CD147 expression in the diagnosis of malignant mesothelioma

The Significance of BRCA-associated Protein (BAP1) and Calretinin Expression in Malignant Pleural Mesothelioma and Non-small Cell Lung Carcinoma: An Immunohistochemical Study

Significance of MUC4 in epithelioid mesothelioma of the pleura, adenocarcinoma & squamous cell carcinoma of the lung (Immunohistochemical Study)

Clinicopathological and Immunohistochemical Study of High Grade Serous Ovarian Carcinoma

Prognostic relevance of immunohistochemical expression of Sox2, YAP1, and IMP3 in non-muscle invasive bladder cancer

Immunohistochemical Study of 5-Methylthioadenosine Phosphorylase (MTAP) and Epithelial Membrane Antigen (EMA) in Differentiating Epithelioid Pleural Mesothelioma from Reactive Me